Has Lilian Ike received payments from drug or device companies?

Yes. Drug and device makers reported $4,405 in general payments to Lilian Ike across 154 transactions between 2019–2025. Most Open Payments records nationally are meals worth under $20; a reported payment is not evidence of wrongdoing.

Does a payment mean Lilian Ike did something wrong?

No. Federal law requires drug and device makers to report almost every transfer of value to a physician, including a $14 sandwich at a lunch presentation. Consulting fees, research funding and royalties to device inventors are ordinary, legal parts of medicine. This site reports what was disclosed; it makes no allegation.

Where does this information about Lilian Ike come from?

The U.S. Centers for Medicare & Medicaid Services. Payments come from Open Payments, published under the Physician Payments Sunshine Act. Billing and prescribing figures come from the Medicare Physician & Other Practitioners and Part D Prescriber public use files for 2024.

Lilian Ike

Psychiatric/Mental Health · Houston, TXNPI 1851806574

Payments from drug & device makers

$4,405in general payments, 2019–2025

Across 154 payments — averaging $28.60 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

Johnson & Johnson$1K
Teva Pharmaceuticals USA, Inc.$610
Alkermes, Inc.$416
Otsuka America Pharmaceutical, Inc.$396
Supernus Pharmaceuticals, Inc.$374
Neurocrine Biosciences, Inc.$371
plus $889 from 11 others

What the payments were for

Food & beverage$4,29898%
Education$1072%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

Company	Payments	Total
Johnson & Johnson	30	$1,348
Teva Pharmaceuticals USA, Inc.	22	$610
Alkermes, Inc.	7	$416
Otsuka America Pharmaceutical, Inc.	18	$396
Supernus Pharmaceuticals, Inc.	43	$374
Neurocrine Biosciences, Inc.	4	$371
E.r. Squibb & Sons, L.L.C.	5	$149
Ironshore Pharmaceuticals Inc.	2	$140
Axsome Therapeutics, Inc.	1	$138
AbbVie	5	$116
Lundbeck LLC	4	$88
Sunovion Pharmaceuticals Inc.	5	$78
Vanda Pharmaceuticals Inc.	2	$57
Indivior Inc.	3	$55
Almatica Pharma LLC	1	$26
ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)	1	$23
Noven Therapeutics, LLC	1	$21

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$4,405 in reported general payments places this provider in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.

See all psychiatric/mental health providers in Texas →

Most prescribed under Part D

Drug	Claims	Cost to plans & patients
Aripiprazole	26	$1,844
Quetiapine Fumarate	54	$1,019
Paliperidone ErPaliperidone	11	$866
Divalproex Sodium ErDivalproex Sodium	17	$819
Mirtazapine	11	$532
Duloxetine Hcl	39	$457
Risperidone	37	$352
Trazodone Hcl	86	$346
Sertraline Hcl	51	$312
Bupropion XlBupropion Hcl	22	$280
Buspirone Hcl	27	$230
Benztropine Mesylate	28	$210
Hydroxyzine Hcl	17	$203
Alprazolam	41	$195
Escitalopram Oxalate	16	$124

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

Company	Paid to this provider	Part D cost of their drugs
Almatica Pharma LLCSertraline Hcl	$26	$31251 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 85th percentile of 2,724 psychiatric/mental health providers in Texas.

Other psychiatric/mental health in Houston

Natalie TellezHouston$602K
Britney PridgenHouston$57K
Linzi LeightonHouston$16K
Samantha SharpeHouston$14K
Jennifer RobinsonHouston$12K
Tracy HicksLongview$684K
Karah BrashierRichardson$567K
Grant DavisRichardson$360K
Victor IlogEl Paso$167K
Lisa ShamblinGrapevine$163K

See the full list for Texas →

Where these figures come from

Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
Identity: NPPES NPI Registry, July 2026.

Is this you, or does something look wrong? →